SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-004386
Filing Date
2023-02-13
Accepted
2023-02-13 07:37:00
Documents
14
Period of Report
2023-02-09
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 41568
2 ex99-1.htm EX-99.1 35661
3 ex99-1_001.jpg GRAPHIC 3329
  Complete submission text file 0001493152-23-004386.txt   268292

Data Files

Seq Description Document Type Size
4 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prvb-20230209.xsd EX-101.SCH 3242
5 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prvb-20230209_lab.xml EX-101.LAB 34916
6 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prvb-20230209_pre.xml EX-101.PRE 22799
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3772
Mailing Address 55 BROAD STREET, 2ND FLOOR RED BANK NJ 07701
Business Address 55 BROAD STREET, 2ND FLOOR RED BANK NJ 07701 908-428-9136
Provention Bio, Inc. (Filer) CIK: 0001695357 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38552 | Film No.: 23614713
SIC: 2834 Pharmaceutical Preparations